Thomas P. Conrads
Professor of Molecular & Cellular Biology and Obstetrics & Gynecology and Chief Scientific Officer of the Department of Defense-Funded Gynecologic Cancer Center of Excellence and the Women's Health Integrated Research Center at Inova Health System.
Gynecologic Cancer Center of Excellence
Molecular and Cellular Biology
Academic Editor on
September 3, 2019
Network-based approach to identify biomarkers predicting response and prognosis for HER2-negative breast cancer treatment with taxane-anthracycline neoadjuvant chemotherapy
Cui Jiang, Shuo Wu, Lei Jiang, Zhichao Gao, Xiaorui Li, Yangyang Duan, Na Li, Tao Sun